These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6510256)

  • 1. Toxicity of anticholinesterases: interactions of pyridostigmine and physostigmine with soman.
    Harris LW; Lennox WJ; Talbot BG; Anderson DR; Swanson DR
    Drug Chem Toxicol; 1984; 7(5):507-26. PubMed ID: 6510256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of carboxylesterase inhibition on carbamate protection against soman toxicity.
    Maxwell DM; Brecht KM; Lenz DE; O'Neill BL
    J Pharmacol Exp Ther; 1988 Sep; 246(3):986-91. PubMed ID: 3418520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral toxicity of anticholinesterases in primates: chronic physostigmine and soman interactions.
    Blick DW; Miller SA; Brown GC; Murphy MR
    Pharmacol Biochem Behav; 1993 Jul; 45(3):677-83. PubMed ID: 8332626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the efficacy of two carbamates, physostigmine and pyridostigmine, when used in conjunction for protection against organophosphate exposure.
    Solana RP; Gennings C; Carter WH; Anderson D; Lennox WJ; Carchman RA; Harris LW
    Fundam Appl Toxicol; 1990 Nov; 15(4):814-9. PubMed ID: 2086320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute behavioral toxicity of pyridostigmine or soman in primates.
    Blick DW; Murphy MR; Brown GC; Yochmowitz MG; Fanton JW; Hartgraves SL
    Toxicol Appl Pharmacol; 1994 Jun; 126(2):311-8. PubMed ID: 8209384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxic interactions between repeated soman and chronic pyridostigmine in rodents.
    Kerenyi SZ; Murphy MR; Hartgraves SL
    Pharmacol Biochem Behav; 1990 Oct; 37(2):267-71. PubMed ID: 2080189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibition and protection of cholinesterase by physostigmine and pyridostigmine against Soman poisoning in vivo.
    Xia DY; Wang LX; Pei SQ
    Fundam Appl Toxicol; 1981; 1(2):217-21. PubMed ID: 7184786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between reversible acetylcholinesterase inhibition and efficacy against soman lethality.
    Lennox WJ; Harris LW; Talbot BG; Anderson DR
    Life Sci; 1985 Sep; 37(9):793-8. PubMed ID: 4033355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of physostigmine and soman using taste aversion and nociception.
    Romano JA; King JM; Penetar DM
    Neurobehav Toxicol Teratol; 1985; 7(3):243-9. PubMed ID: 4033865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral toxicity of anticholinesterases in primates: chronic pyridostigmine and soman interactions.
    Blick DW; Kerenyi SZ; Miller S; Murphy MR; Brown GC; Hartgraves SL
    Pharmacol Biochem Behav; 1991 Mar; 38(3):527-32. PubMed ID: 2068189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of carbamates on whole blood cholinesterase activity: chemical protection against soman.
    Heyl WC; Harris LW; Stitcher DL
    Drug Chem Toxicol; 1980; 3(3):319-32. PubMed ID: 7449657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of subchronic pyridostigmine pretreatment on the toxicity of soman.
    Shiloff JD; Clement JG
    Can J Physiol Pharmacol; 1986 Jul; 64(7):1047-9. PubMed ID: 3768795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of subacute administration of physostigmine on blood acetylcholinesterase activity, motor performance, and soman intoxication.
    Harris LW; Anderson DR; Lennox WJ; Solana RP
    Toxicol Appl Pharmacol; 1989 Feb; 97(2):267-71. PubMed ID: 2922758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of physostigmine as a pretreatment for organophosphate poisoning.
    Miller SA; Blick DW; Kerenyi SZ; Murphy MR
    Pharmacol Biochem Behav; 1993 Feb; 44(2):343-7. PubMed ID: 8446666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subchronic administration of various pretreatments of nerve agent poisoning. II. Compared efficacy against soman toxicity.
    Lallement G; Foquin A; Dorandeu F; Baubichon D; Carpentier P
    Drug Chem Toxicol; 2001 May; 24(2):165-80. PubMed ID: 11360433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time Course, Behavioral Safety, and Protective Efficacy of Centrally Active Reversible Acetylcholinesterase Inhibitors in Cynomolgus Macaques.
    Hamilton LR; Schachter SC; Myers TM
    Neurochem Res; 2017 Jul; 42(7):1962-1971. PubMed ID: 27900576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against both lethal and behavioral effects of soman.
    Harris LW; McDonough JH; Stitcher DL; Lennox WJ
    Drug Chem Toxicol; 1984; 7(6):605-24. PubMed ID: 6534735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of poisoning by soman.
    Leadbeater L; Inns RH; Rylands JM
    Fundam Appl Toxicol; 1985 Dec; 5(6 Pt 2):S225-31. PubMed ID: 4092890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyridostigmine-induced decrement in skeletal muscle contracture is not augmented by soman.
    Anderson RJ; Chamberlain WL
    Neurotoxicology; 1988; 9(1):89-96. PubMed ID: 3393305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro kinetic interactions of pyridostigmine, physostigmine and soman with erythrocyte and muscle acetylcholinesterase from different species.
    Herkert NM; Thiermann H; Worek F
    Toxicol Lett; 2011 Sep; 206(1):41-6. PubMed ID: 21414391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.